CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 901024039
- Phone
- 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K/A Event Exhibits
- 8-K Event Other events
- 8-K Event Agreement ended
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
Page 3 of 6 · 116 filings